This application is also related to commonly assigned U.S. patent application Ser. No. 09/907,895, filed on Jul. 12, 2001, now issued as U.S. Pat. No. 6,721,594, the specification of which is incorporated herein by reference.
The present invention relates generally to implantable medical devices. More particularly, it pertains to displaying arrhythmia episodes based on data taken from implantable medical devices.
A normal human heart beats between 60 to 100 times per minute. However, when a person gets excited or frightened or has an illness such as congenital heart disease, the heart may beat faster than 100 times per minute. A disruption in the normal heart rate or rhythm is known as arrhythmia.
Arrhythmias are caused by abnormal functioning of the electrical conduction of the heart. Normally, the chambers of the heart (atria and ventricles) work in a coordinated manner. The electrical conduction begins with an electrical impulse originating in the sinoatrial node. This impulse is then moved through the atria, stimulates them to contract, and then is moved to its final destination at the ventricles, where it stimulates them to contract also. Any problems along this conduction path may cause arrhythmias.
Certain types of arrhythmia are lethal and may cause severe damage to various organs in the body by initially decreasing the pumping of the heart. When the pumping of the heart is decreased by more than a few seconds, blood circulation is essentially stopped, and organ damage (such as brain damage) may occur within a few minutes.
Arrhythmias have been treated by the use of a pacemaker that applies shock therapy. A pacemaker is a medical device that delivers controlled electrical pulses to an electrode that is implanted adjacent to or in the heart. These controlled electrical pulses stimulate the heart so that it will contract and beat at a desired rate. The delivery of these controlled electrical pulses is often tailored to the individual patient.
A physician at times needs to reassess the therapy applied by the pacemaker. One technique is for the physician to obtain a printed listing of the therapy data from the pacemaker and reformulate the therapy. However, what has been frustrating for the physician is that the use of the listing of data to reformulate the therapy has been laborious, time-intensive, and error-prone.
Thus, what is needed are systems, devices, structures, and methods to ease the use of the therapy data by a physician.
The above-mentioned problems with the use of data from an implantable medical device as well as other problems are addressed by the present invention and will be understood by reading and studying the following specification. Systems, devices, structures, and methods are described which ease the use of therapy data by a physician.
In particular, an illustrative embodiment includes an exemplary display. This display comprises a first graph to show a frequency of at least one type of ventricular arrhythmia over a predetermined amount of time. The display also comprises a second graph to show a frequency of at least one type of atrial arrhythmia over the predetermined amount of time.
Another illustrative embodiment includes an exemplary method of performing a medical diagnostic. The method comprises receiving data stored in an implantable medical device, viewing a display that includes at least one graph showing the frequency of at least one type of arrhythmia over a predetermined period of time. The graph is formed from the data received from the implantable medical device. The method further comprises deriving a diagnostic based at least on the graph.
A further illustrative embodiment includes an exemplary method of therapy. The method comprises viewing a display that includes at least one graph showing the frequency of at least one type of arrhythmia over a predetermined period of time. The method further comprises deriving a set of programming variable values based at least on the graph to program an implantable medical device. The method further comprises transmitting the set of programming variable values to the implantable medical device so as to apply a therapy when a patient experiences a predetermined type of arrhythmia.
A further illustrative embodiment includes an exemplary system. The system comprises an implantable medical device. The implantable medical device includes a controller to control the implantable medical device, memory coupled to the controller to store at least one occurrence of at least one type of arrhythmia over a predetermined period of time, and a medical device transmitter coupled to the controller to transmit the at least one occurrence of the at least one type of arrhythmia. The system further comprises a programmer. The programmer includes a processor to control the programmer, a programmer receiver coupled to the processor to receive the at least one occurrence of the at least one type of arrhythmia, and a display that includes at least one graph showing the frequency of the at least one occurrence of the at least one type of arrhythmia over the predetermined period of time.
A further illustrative embodiment includes an exemplary data structure. The data structure comprises at least one count variable to contain a count of a frequency of the at least one type of arrhythmia. The data structure further comprises a recorded episode data structure to ascertain that at least one type of arrhythmia is present, wherein once the recorded episode data structure ascertains that at least one type of arrhythmia is present, the one count variable for the type of arrhythmia is incremented.
A further illustrative embodiment includes a programmer. The programmer comprises a processor to control the programmer, a programmer receiver coupled to the processor to receive at least one occurrence of at least one type of arrhythmia, and a display that includes at least one graph showing the frequency of at least one occurrence of at least one type of arrhythmia over the predetermined period of time.
A further illustrative embodiment includes a method of presenting at least one type of arrhythmia. The method comprises monitoring a heart rate over a first predetermined duration, triggering when the heart rate reaches a predetermined threshold over the first predetermined duration to define a detected arrhythmia episode, recording when the detected arrhythmia episode is sustained over a second predetermined duration and a therapy is applied, and displaying at least one graph to show the frequency of the detected arrhythmia episode over a predetermined period of time.
These and other embodiments, aspects, advantages, and features of the present invention will be set forth in part in the description which follows, and in part will become apparent to those skilled in the art by reference to the following description of the invention and drawings or by practice of the invention. The aspects, advantages, and features of the invention are realized and attained by means of the instrumentalities, procedures, and combinations particularly pointed out in the appended claims.
In the following detailed description of the invention, reference is made to the accompanying drawings that form a part hereof, and in which are shown, by way of illustration, specific embodiments in which the invention may be practiced. In the drawings, like numerals describe substantially similar components throughout the several views. These embodiments are described in sufficient detail to enable those skilled in the art to practice the invention. Other embodiments may be utilized and structural, logical, and electrical changes may be made without departing from the scope of the present invention.
The embodiments described herein focus on visual communication of data to a professional, such as a physician, who is making a diagnostic or changing a therapy for a patient having an implantable medical device, such as a pacemaker, implantable cardioverter defibrillator, or defibrillator.
Implantable cardioverter defibrillators are designed to detect and provide therapy for various types of arrhythmia that include ventricular tachycardia and ventricular fibrillation. Each device may include a pulse generator to generate pulses that may be used in a therapy session. An external component, such as a programmer, allows interrogation and programming of the pulse generator, as well as access to the device's diagnostic features. Each device can be programmed to provide a variety of detection options. Each can also provide noninvasive diagnostic testing and therapy history data. In one embodiment, an implantable cardioverter defibrillator may also act as a pacer.
In the case of an implantable cardioverter defibrillator, the embodiments provide for a presentation that enables a physician to quickly analyze the history of shock therapy that has been applied to the patient by the implantable cardioverter defibrillator over a period of time. Certain conclusions that can be drawn from looking at the visual history provided by the embodiments include whether the patient is experiencing a lot of shock therapy, whether the shock therapy is applied infrequently, or whether the therapy is applied regularly. Based on conclusions drawn from the presentation of the embodiments, the physician may decide to adjust the therapy delivered by the implantable cardioverter defibrillator, or to medicate the patient with antiarrhythmic medications, or both.
The graph 102 includes symbols 1080, 1081, 1082, . . . , and 108N. Each symbol is indicative of the type of arrhythmia that was detected by an implantable cardioverter defibrillator implanted in a patient. In one embodiment, the type of arrhythmia includes ventricular arrhythmia. In another embodiment, ventricular arrhythmia includes ventricular fibrillation, sustained ventricular tachycardia, or non-sustained ventricular tachycardia. In one embodiment, sustained ventricular tachycardia is understood to mean the inclusion of a detected ventricular tachycardia for a predetermined period of time for which an appropriate shock therapy was delivered. In another embodiment, non-sustained ventricular tachycardia is understood to mean the inclusion of a detected ventricular tachycardia for which shock therapy was not delivered because such detection did not meet additional criteria, such as the duration of the occurrence of the detected ventricular tachycardia.
In the chart 102, the symbol 1080 is indicative of detected episodes of ventricular fibrillation. The symbol 1081 is indicative of detected episodes of ventricular tachycardia. The symbol 1082 is indicative of detected episodes of user-defined ventricular tachycardia. The symbol 108N is indicative of detected episodes of non-sustained ventricular tachycardia. In one embodiment, a user can define a zone of interest within a detection of ventricular tachycardia. When a ventricular tachycardia occurs within this zone of interest, its frequency may be recorded and displayed by the symbol 1082. The zone of interest includes a dependency on a user-programmed range of heart rates. In another embodiment, the user can define three zones of interest. In another embodiment, a zone is a range of heart rates that is programmed for each type of tachyarrhythmia that can be treated by a separate therapy prescription.
Symbols 1080, 1081, 1082, . . . , 108N may be composed of diverse symbol types, colors, patterns, fills, and line-widths. In chart 102, these symbols are columns with distinguishing patterns and fills. The term symbol types is not limited to the column symbol as shown in
Symbols 1080, 1081, 1082, . . . , 108N may be grouped together in a cluster. In chart 102, clusters 1260, 1261, 1262, 1263, 1264, . . . , 126N represent a time period when the episodes of various types of arrhythmia were detected. In one embodiment, the time period is about five months. In another embodiment, the time period is greater than about five months. In another embodiment, the time period is less than about five months.
The chart 102 includes a legend 104. The legend 104 explains the symbols on the chart 102. In one embodiment, the legend 104 explains the symbols on the chart 102 by associating a text label with a sample of the specific symbol.
The chart 102 includes numerical data label 106 on the ordinate of the chart 102. The data label 106 is indicative of the number of episodes of detected arrhythmia. In one embodiment, the numerical data in label 106 are selectively scaled based on the range of frequency of the detected episodes of various types of arrhythmia.
The chart 102 includes gridlines 116. The gridlines 116 are placed at predetermined intervals to visually communicate the level of frequency with respect to the symbols 1080, 1081, 1082, . . . , 108N.
The display 100 also includes a chart 110. In one embodiment, the chart 110 contains graphical elements as described above and so the above description is incorporated here. In one embodiment, the chart 110 contains symbol 128. This symbol is indicative of the type of arrhythmia that was detected by an implantable cardioverter defibrillator implanted in a patient. In one embodiment, as demonstrated by
The display 100 includes a title 120. In one embodiment, this title is user-definable and may be placed at the top to be conspicuous. In another embodiment, the display 100 automatically displays a pre-set title 120. The title 120 serves to communicate the purpose of the display 100. The display 100 also includes a data title 122. This data title 122 serves to communicate the purpose of the numerical data labels 106 and 112.
The display 100 also includes an electrogram display 132. The electrogram display 132 shows intervals that are the time difference from beat to beat. The electrogram display 132 also shows markers. Markers are labels of the type of arrhythmia on the electrogram. For example, if ventricular tachycardia is on the electrogram, the region of the electrogram associated with this arrhythmia would be labeled VT. The electrogram display 132 may automatically provide electrogram channel display appropriate for the arrhythmia activities shown or other cardiac activities.
The system 400 includes a programmer 414. The programmer 414 includes a processor 416 to control the programmer 414. The programmer 414 includes a coupling network 418, such as a bus. The programmer 414 includes a programmer receiver 424. In one embodiment, the programmer receiver 424 is receptive to a transmission from the transmitter 408 to receive each count for each occurrence of each detected type of arrhythmia that the patient experiences. The programmer 414 includes a programmer transmitter 420. In one embodiment, the programmer transmitter 420 is used to reprogram the implantable medical device 402 to apply a different therapy when a type of arrhythmia is detected. The programmer transmitter 420 can also be used to transmit a detection zone of interest which the device 402 classifies after detecting a type of arrhythmia. The programmer 414 includes a display 422. The display 422 is capable of displaying at least one graph showing the frequency of each detected type of arrhythmia that the patient has experienced over a predetermined period of time, such as five months or greater. The display 422 is capable of displaying the frequency associated with the types of arrhythmia specified within the zone of interest. In one embodiment, the zone of interest is specifiable by a user, and is can be transmitted by the programmer transmitter 420 to the device 402.
The data structure 500 includes a variable “ventricular fibrillation” 502 to store a count of each occurrence of detected ventricular fibrillation that a patient experiences over a predetermined period of time, such as five months. The data structure 500 includes a variable “ventricular tachycardia” 504 to store a count of each occurrence of detected ventricular tachycardia that a patient experiences over the same predetermined period of time as used in variable 502. The data structure 500 includes a variable “ventricular tachycardia 1” 506 to store a count of each occurrence of a detected user-defined zone of interest for ventricular tachycardia that a patient experiences over the same predetermined period of time as used in variable 502. The data structure 500 includes a variable “non-sustained ventricular tachycardia” 508 to store a count of each occurrence of detected arrhythmia that did not meet other criteria for a therapy to be delivered to the patient. In another embodiment, variables 502, 504, and 506 store a count of each occurrence of a different detected user-defined zone of interest.
In one embodiment, the data structure 500 includes a data structure entitled detected episode 510. In another embodiment, the data structure 500 contains a pointer to the detected episode data structure 510. In one embodiment, the detected episode data structure 510 contains information that at least one type of arrhythmia has been detected based on a number of criteria, such as heart rate. The data structure 500 also includes a data structure entitled recorded episode 512. In another embodiment, the data structure 500 contains a pointer to the recorded episode data structure 512. In one embodiment, the recorded episode data structure 512 contains information to confirm that the detected arrhythmia is present according to additional criteria, such as the duration of the detected arrhythmia. If the recorded episode data structure 512 confirms that a detected arrhythmia is present in the patient, one of the appropriate variables 502, 504, 506, or 508 will be incremented to reflect the occurrence of the detected arrhythmia.
Next, the method 600 continues to monitor the detected arrhythmia and apply additional criteria at block 606. For example, if the detected arrhythmia episode is sustained over another predetermined duration of time, a therapy may be applied. Depending on the outcome of the therapy, the block 606 records and classifies the occurrence of the particular type of arrhythmia. In one embodiment, the block 606 simply records the occurrence of the detected type of arrhythmia as detected in block 604.
In one embodiment, the above flow may be iterated for a predetermined period of time, such as five months. In another embodiment, only individual blocks, such as block 602 or block 604, or both are iterated. At the end of this period, the recorded data is transmitted to a display. At block 608, the display reformats the data to present a visual presentation that is easy to understand to a professional, such as a physician.
Thus, systems, devices, structures, and methods have been described to visually present data from an implantable medical device to a professional, such as a physician.
Although the specific embodiments have been illustrated and described herein, it will be appreciated by those of ordinary skill in the art that any arrangement which is calculated to achieve the same purpose may be substituted for the specific embodiment shown. This application is intended to cover any adaptations or variations of the present invention. It is to be understood that the above description is intended to be illustrative and not restrictive. Combinations of the above embodiments and other embodiments will be apparent to those of skill in the art upon reviewing the above description. The scope of the invention includes any other applications in which the above structures and fabrication methods are used. Accordingly, the scope of the invention should only be determined with reference to the appended claims, along with the full scope of equivalents to which such claims are entitled.
This application is a continuation of U.S. patent application Ser. No. 09/905,054, filed on Jul. 12, 2001, now issued as U.S. Pat. No. 6,718,198, which is a division of U.S. patent application Ser. No. 09/382,292, filed on Aug. 24, 1999, now issued as U.S. Pat. No. 6,449,504, which is a continuation-in-part of U.S. patent application Ser. No. 09/378,030, filed on Aug. 20, 1999, now abandoned, the specifications of which are incorporated herein by reference.
Number | Name | Date | Kind |
---|---|---|---|
4006737 | Cherry | Feb 1977 | A |
4090505 | Mortara | May 1978 | A |
4166470 | Neumann | Sep 1979 | A |
4172459 | Hepp | Oct 1979 | A |
4187854 | Hepp et al. | Feb 1980 | A |
4197850 | Schulman et al. | Apr 1980 | A |
4223678 | Langer et al. | Sep 1980 | A |
4232679 | Schulman | Nov 1980 | A |
4236524 | Powell et al. | Dec 1980 | A |
4316249 | Gallant et al. | Feb 1982 | A |
4336810 | Anderson et al. | Jun 1982 | A |
4407288 | Langer et al. | Oct 1983 | A |
4509530 | Curtis et al. | Apr 1985 | A |
4527567 | Fischler et al. | Jul 1985 | A |
4529401 | Leslie et al. | Jul 1985 | A |
4531527 | Reinhold, Jr. et al. | Jul 1985 | A |
4549552 | Groch et al. | Oct 1985 | A |
4596255 | Snell et al. | Jun 1986 | A |
4601291 | Boute et al. | Jul 1986 | A |
4680708 | Ambos et al. | Jul 1987 | A |
4791936 | Snell et al. | Dec 1988 | A |
4800883 | Winstrom | Jan 1989 | A |
4802491 | Cohen et al. | Feb 1989 | A |
4809697 | Causey, III et al. | Mar 1989 | A |
4825869 | Sasmor et al. | May 1989 | A |
4850357 | Bach, Jr. | Jul 1989 | A |
4944298 | Sholder | Jul 1990 | A |
4947857 | Albert et al. | Aug 1990 | A |
4958632 | Duggan | Sep 1990 | A |
4964410 | Leahey et al. | Oct 1990 | A |
4974598 | John | Dec 1990 | A |
4979506 | Silvian | Dec 1990 | A |
4989610 | Patton et al. | Feb 1991 | A |
4998531 | Bocchi et al. | Mar 1991 | A |
5000189 | Throne et al. | Mar 1991 | A |
5012814 | Mills et al. | May 1991 | A |
5027824 | Dougherty et al. | Jul 1991 | A |
5046504 | Albert et al. | Sep 1991 | A |
5047930 | Martens et al. | Sep 1991 | A |
5050612 | Matsumura | Sep 1991 | A |
5052395 | Burton et al. | Oct 1991 | A |
5111816 | Pless et al. | May 1992 | A |
5113869 | Nappholz et al. | May 1992 | A |
5129392 | Bardy et al. | Jul 1992 | A |
5184614 | Collins et al. | Feb 1993 | A |
5193550 | Duffin | Mar 1993 | A |
5209228 | Cano et al. | May 1993 | A |
5215083 | Drane et al. | Jun 1993 | A |
5217021 | Steinhaus et al. | Jun 1993 | A |
5224475 | Berg et al. | Jul 1993 | A |
5273049 | Steinhaus et al. | Dec 1993 | A |
5279293 | Andersen et al. | Jan 1994 | A |
5292341 | Snell | Mar 1994 | A |
5299118 | Martens et al. | Mar 1994 | A |
5309919 | Snell et al. | May 1994 | A |
5311873 | Savard et al. | May 1994 | A |
5311874 | Baumann et al. | May 1994 | A |
5312441 | Mader et al. | May 1994 | A |
5315512 | Roth | May 1994 | A |
5341811 | Cano | Aug 1994 | A |
5342402 | Olson et al. | Aug 1994 | A |
5344430 | Berg et al. | Sep 1994 | A |
5357969 | Herleikson | Oct 1994 | A |
5391188 | Nelson et al. | Feb 1995 | A |
5402794 | Wahlstrand et al. | Apr 1995 | A |
5404877 | Nolan et al. | Apr 1995 | A |
5404880 | Throne | Apr 1995 | A |
5411530 | Akhtar | May 1995 | A |
5413594 | Williams | May 1995 | A |
5417714 | Levine et al. | May 1995 | A |
5421830 | Epstein et al. | Jun 1995 | A |
5423871 | Hoegnelid et al. | Jun 1995 | A |
5431692 | Hansen et al. | Jul 1995 | A |
5458623 | Lu et al. | Oct 1995 | A |
5464433 | White et al. | Nov 1995 | A |
5476485 | Weinberg et al. | Dec 1995 | A |
5487754 | Snell et al. | Jan 1996 | A |
5487755 | Snell et al. | Jan 1996 | A |
5496351 | Plicchi et al. | Mar 1996 | A |
5507786 | Morgan et al. | Apr 1996 | A |
5511553 | Segalowitz | Apr 1996 | A |
5513645 | Jacobson et al. | May 1996 | A |
5535753 | Petrucelli et al. | Jul 1996 | A |
5549646 | Katz et al. | Aug 1996 | A |
5549654 | Powell | Aug 1996 | A |
5555888 | Brewer et al. | Sep 1996 | A |
5578063 | Bocek et al. | Nov 1996 | A |
5584298 | Kabal | Dec 1996 | A |
5586556 | Spivey et al. | Dec 1996 | A |
5591214 | Lu | Jan 1997 | A |
5603331 | Heemels et al. | Feb 1997 | A |
5607460 | Kroll et al. | Mar 1997 | A |
5609612 | Plicchi et al. | Mar 1997 | A |
5609615 | Sanders et al. | Mar 1997 | A |
5613495 | Mills et al. | Mar 1997 | A |
5620474 | Koopman | Apr 1997 | A |
5626620 | Kieval et al. | May 1997 | A |
5626623 | Kieval et al. | May 1997 | A |
5628321 | Scheib et al. | May 1997 | A |
5628776 | Paul et al. | May 1997 | A |
5643255 | Organ | Jul 1997 | A |
5647369 | Petrucelli et al. | Jul 1997 | A |
5653737 | van Lake | Aug 1997 | A |
5674249 | de Coriolis et al. | Oct 1997 | A |
5683431 | Wang | Nov 1997 | A |
5687737 | Branham et al. | Nov 1997 | A |
5693075 | Plicchi et al. | Dec 1997 | A |
5697959 | Poore | Dec 1997 | A |
5709712 | Paul et al. | Jan 1998 | A |
5713366 | Armstrong et al. | Feb 1998 | A |
5716383 | Kieval et al. | Feb 1998 | A |
5716384 | Snell | Feb 1998 | A |
5722999 | Snell | Mar 1998 | A |
5724985 | Snell et al. | Mar 1998 | A |
5732708 | Nau et al. | Mar 1998 | A |
5743268 | Kabal | Apr 1998 | A |
5749900 | Schroeppel et al. | May 1998 | A |
5749906 | Kieval et al. | May 1998 | A |
5749907 | Mann | May 1998 | A |
5755742 | Schuelke et al. | May 1998 | A |
5759196 | Hess et al. | Jun 1998 | A |
5759199 | Snell et al. | Jun 1998 | A |
5772604 | Langberg et al. | Jun 1998 | A |
5782890 | Wahlstrand et al. | Jul 1998 | A |
5788640 | Peters | Aug 1998 | A |
5792203 | Schroeppel | Aug 1998 | A |
5792204 | Snell | Aug 1998 | A |
5792207 | Dietrich | Aug 1998 | A |
5814083 | Hess et al. | Sep 1998 | A |
5814088 | Paul et al. | Sep 1998 | A |
5817137 | Kaemmerer | Oct 1998 | A |
5833623 | Mann et al. | Nov 1998 | A |
5876353 | Riff | Mar 1999 | A |
5891043 | Ericksen et al. | Apr 1999 | A |
5891178 | Mann et al. | Apr 1999 | A |
5891179 | Er et al. | Apr 1999 | A |
5897577 | Cinbis et al. | Apr 1999 | A |
5924989 | Polz | Jul 1999 | A |
5925067 | Lu | Jul 1999 | A |
5951484 | Hoium et al. | Sep 1999 | A |
5954664 | Seegobin | Sep 1999 | A |
5957861 | Combs et al. | Sep 1999 | A |
5961467 | Shimazu et al. | Oct 1999 | A |
5974341 | Er et al. | Oct 1999 | A |
5978707 | Krig et al. | Nov 1999 | A |
6004276 | Wright et al. | Dec 1999 | A |
6007493 | Ericksen et al. | Dec 1999 | A |
6016442 | Hsu et al. | Jan 2000 | A |
6016446 | Belalcazar | Jan 2000 | A |
6016447 | Juran et al. | Jan 2000 | A |
6016448 | Busacker et al. | Jan 2000 | A |
6017307 | Raines | Jan 2000 | A |
6035233 | Schroeppel et al. | Mar 2000 | A |
6067471 | Warren | May 2000 | A |
6076015 | Hartley et al. | Jun 2000 | A |
6091990 | Hsu et al. | Jul 2000 | A |
6095984 | Amano et al. | Aug 2000 | A |
6101415 | Er et al. | Aug 2000 | A |
6108577 | Benser | Aug 2000 | A |
6112117 | KenKnight et al. | Aug 2000 | A |
6243606 | Mann et al. | Jun 2001 | B1 |
6253102 | Hsu et al. | Jun 2001 | B1 |
6263244 | Mann et al. | Jul 2001 | B1 |
6289244 | Conley et al. | Sep 2001 | B1 |
6289248 | Conley et al. | Sep 2001 | B1 |
6301503 | Hsu et al. | Oct 2001 | B1 |
6308095 | Hsu et al. | Oct 2001 | B1 |
6311089 | Mann et al. | Oct 2001 | B1 |
6312378 | Bardy | Nov 2001 | B1 |
6415175 | Conley et al. | Jul 2002 | B1 |
6418340 | Conley et al. | Jul 2002 | B1 |
6449504 | Conley et al. | Sep 2002 | B1 |
6459929 | Hopper et al. | Oct 2002 | B1 |
6459934 | Kadhiresan | Oct 2002 | B1 |
6477404 | Yonce et al. | Nov 2002 | B1 |
6535763 | Hiebert et al. | Mar 2003 | B1 |
6665558 | Kalgren et al. | Dec 2003 | B2 |
6718198 | Conley et al. | Apr 2004 | B2 |
6721594 | Conley et al. | Apr 2004 | B2 |
6843801 | Conley et al. | Jan 2005 | B2 |
20020077859 | Stahmann et al. | Jun 2002 | A1 |
20030114891 | Hiebert et al. | Jun 2003 | A1 |
20040082976 | Kalgren et al. | Apr 2004 | A1 |
20050107840 | Conley et al. | May 2005 | A1 |
Number | Date | Country |
---|---|---|
0491649 | Jun 1992 | EP |
0558353 | Sep 1993 | EP |
0565084 | Oct 1993 | EP |
0711531 | May 1996 | EP |
0850661 | Jul 1998 | EP |
WO-9927992 | Jun 1999 | WO |
Number | Date | Country | |
---|---|---|---|
20040143306 A1 | Jul 2004 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 09382292 | Aug 1999 | US |
Child | 09905054 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 09905054 | Jul 2001 | US |
Child | 10747391 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 09378030 | Aug 1999 | US |
Child | 09382292 | US |